Article

Artificial Intelligence in Drug Discovery: A New Paradigm from Target Identification to Clinical Translation

2025-10-30

Abstract excerpt

The drug discovery process is historically characterized by high costs, protracted timelines, and substantial attrition rates. Artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), is now fundamentally reshaping this landscape by introducing unprecedented speed, efficiency, and predictive power. This comprehensive review delineates the transformative impact of AI across the entir...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cf7b0c9f-99b9-5eca-9491-559f79dc0e2d
DOI: 10.22541/au.176184278.86885419/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Artificial Intelligence in Drug Discovery: A New Paradigm from Target Identification to Clinical TranslationDOI 10.22541/au.176184278.86885419/v1Read

Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular DesignSemantic proximity Read

Drug Discovery in the Era of Artificial Intelligence: From Target Identification to Clinical TrialsSemantic proximity Read

Role of Artificial Intelligence in Modern Drug Discovery: A Literature OverviewSemantic proximity Read

A Comprehensive Review on Deep Learning for Genomics and AI in Drug DiscoverySemantic proximity Read

Pan–Pharmacological Drug–Target Interaction Prediction with 3D–Informed Protein Encoding at ScaleSemantic proximity Read

Integrating Artificial Intelligence with Genomic and Biomarker Data for the Advancement of Personalized Therapeutics in a Human-Centric FrameworkSemantic proximity Read

Structure-free, site-resolved contrastive learning extends small-molecule discovery beyond the reach of structure-based modelingSemantic proximity Read

Application of Machine Learning in Translational Medicine: Current Status and Future OpportunitiesSemantic proximity Read

Lab-in-the-loop therapeutic antibody design with deep learningSemantic proximity Read

Generative Drug Design in a Loop with dtSFMSemantic proximity Read

Deep contrastive learning enables genome-wide virtual screeningSemantic proximity Read

Machine learning-guided drug repurposing for EGFR inhibition using scaffold-split validation, docking, and molecular dynamics.Semantic proximity Read